COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Authors
Keywords
-
Journal
HemaSphere
Volume 7, Issue 1, Pages e811
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-12-21
DOI
10.1097/hs9.0000000000000811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID ‐19 vaccine response in patients with hematologic malignancy: A systematic review and meta‐analysis
- (2022) Inna Y. Gong et al. AMERICAN JOURNAL OF HEMATOLOGY
- COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
- (2022) Lindsey Wang et al. BLOOD REVIEWS
- The impact of B‐cell‐directed therapy on SARS‐CoV ‐2 vaccine efficacy in chronic lymphocytic leukaemia
- (2022) Chaitra Ujjani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Third dose of COVID‐19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titers
- (2022) O. Šušol et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
- (2022) Helen Parry et al. Journal of Hematology & Oncology
- Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
- (2022) Sue Ann Costa Clemens et al. LANCET
- COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study
- (2022) Оlga L. Kochneva et al. LEUKEMIA & LYMPHOMA
- Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
- (2022) Bartosz Puła et al. Cancers
- Managing hematological cancer patients during the COVID-19 pandemic: An ESMO-EHA Interdisciplinary Expert Consensus
- (2022) Christian Buske et al. ESMO Open
- Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study
- (2022) J. Erika Haydu et al. Blood Advances
- Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
- (2022) Sabine Haggenburg et al. Blood Advances
- COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
- (2022) Helen Parry et al. CANCER CELL
- Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
- (2022) Anna R. Giuliano et al. JAMA Oncology
- Vaccinations in CLL: implications for COVID-19
- (2021) Mazyar Shadman et al. BLOOD
- Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
- (2021) Petra Langerbeins et al. ACTA HAEMATOLOGICA
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
- (2021) Lindsey E. Roeker et al. LEUKEMIA
- BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies
- (2021) Katrin Herzog Tzarfati et al. AMERICAN JOURNAL OF HEMATOLOGY
- COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
- (2021) Lindsey Elizabeth Roeker et al. BLOOD
- Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
- (2021) Lee M. Greenberger et al. CANCER CELL
- Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
- (2021) Lee M. Greenberger et al. CANCER CELL
- Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia
- (2021) Ohad Benjamini et al. HAEMATOLOGICA
- COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients
- (2021) Giovanni Del Poeta et al. HEMATOLOGICAL ONCOLOGY
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
- (2021) Tamar Tadmor et al. LEUKEMIA
- Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL
- (2021) Clare Sun et al. BLOOD
- COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic
- (2021) Shlomzion Aumann et al. BLOOD
- Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Gilad Itchaki et al. BLOOD
- Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)
- (2021) Nicole K. Yun et al. BLOOD
- Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies
- (2021) Thomas A. Ollila et al. BLOOD
- Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies
- (2021) Ning Dong et al. BLOOD
- Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination
- (2021) Yair Herishanu et al. BLOOD
- COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis
- (2021) Inna Gong et al. BLOOD
- Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
- (2021) Patrick Reimann et al. BRITISH JOURNAL OF HAEMATOLOGY
- COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity
- (2021) Yandong Shen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study
- (2021) Stefano Molica et al. CHEMOTHERAPY
- mRNA COVID‐19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta‐analysis
- (2021) Stefano Molica et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis
- (2021) Nico Gagelmann et al. HAEMATOLOGICA
- Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
- (2021) Arabella S V Stuart et al. LANCET
- COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
- (2021) Thomas Chatzikonstantinou et al. LEUKEMIA
- Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
- (2021) Kristina L. Bajema et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
- (2021) Peter Bergman et al. EBioMedicine
- Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
- (2021) Rüdiger Groß et al. EBioMedicine
- Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: a systematic review and meta-analysis
- (2021) Joanne S.K. Teh et al. Blood Advances
- Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
- (2021) Yair Herishanu et al. Blood Advances
- Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
- (2021) Cristina Bagacean et al. Blood Advances
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
- (2020) Lydia Scarfò et al. LEUKEMIA
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started